Avenue Therapeutics, Inc. Recorded Big Gain

Wed, Sep 14, 2022 at 07:33 PM
Avenue Therapeutics, Inc. Recorded Big Gain

Avenue Therapeutics, Inc. (ATXI:NASDAQ) soared at $0.36, a gain of 53.2%. On Wed, Sep 14, 2022, ATXI:NASDAQ hit a New 2-Week High of $0.36. From Wed, Aug 31, 2022, the stock recorded 33.33% Up Days and 50.00% Green Days

The stock spiked on Wed, Sep 14, 2022 at $0.59 with a volume of 65M+.

About Avenue Therapeutics, Inc. (ATXI:NASDAQ)

Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of an intravenous, or IV, formulation of tramadol HCl, or IV Tramadol, for the management of moderate to moderately severe postoperative pain.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.